|
Oct 10
|
Here’s Why BeiGene, Ltd. (BGNE) Rallied in Q3
|
|
Oct 7
|
BeiGene (BGNE) Moves 5.3% Higher: Will This Strength Last?
|
|
Aug 28
|
Wall Street Analysts See a 27.84% Upside in BeiGene (BGNE): Can the Stock Really Move This High?
|
|
Aug 28
|
3 US Stocks That Could Be Trading At A Discount
|
|
Aug 28
|
BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
|
|
Aug 27
|
FDA grants fast track status to BeiGene’s BGB-16673 for CLL/SLL
|
|
Aug 26
|
BeiGene, Ltd. (BGNE) Just Flashed Golden Cross Signal: Do You Buy?
|
|
Aug 26
|
BeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLL
|
|
Aug 9
|
BeiGene Second Quarter 2024 Earnings: Beats Expectations
|
|
Aug 8
|
Beyond the Balance Sheet: What SWOT Reveals About BeiGene Ltd (BGNE)
|
|
Aug 7
|
BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates
|
|
Jul 24
|
BeiGene opens biologics facility in New Jersey, US
|
|
Jul 23
|
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World
|
|
Jul 18
|
BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer
|
|
Jun 27
|
Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)
|
|
Jun 14
|
BeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA® plus Venetoclax in High-Risk First-Line CLL/SLL at EHA2024
|
|
Jun 13
|
BeiGene and NewBridge Pharmaceuticals FZ LLC Mutually Agree to Conclude BRUKINSA® (Zanubrutinib) Partnership in the Middle East and Africa (MENA) Region
|
|
Jun 13
|
BeiGene, Ltd. (NASDAQ:BGNE) Shares Could Be 47% Below Their Intrinsic Value Estimate
|
|
Mar 27
|
Shareholders in BeiGene (NASDAQ:BGNE) have lost 54%, as stock drops 8.5% this past week
|
|
Jan 5
|
3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024
|